Top Stories
Vivid Explorer, Vivid Advanced and Vivid Focus have all received CE marking in the EU and are pending FDA 510(k) clearance in the US.
The healthcare data infrastructure startup, backed by Y Combinator, plans to use the funding to expand its AI, machine learning and agentic capabilities.
The model was best at distinguishing women with and without stroke, followed by hypertension and ischaemic heart disease.
The funding will support an AI-driven search for new proteins linked to the pregnancy complications.
Headspace disclosed that the deal could result in cuts to corporate staff where functions overlap between the two companies.
Conference News
Implantation of an ICD did not significantly reduce sudden cardiac death (SCD) or hemodynamically significant ventricular arrhythmia (HSVA) compared with an implantable loop recorder (ILR) in patients...
-- Chiesi’s abstract presentations highlight clinical insights and patient-reported outcomes in Fabry disease and alpha-mannosidosis ---- Rooted in patient voice and scientific rigor, this research re...
FAIRFAX, VA, UNITED STATES, August 27, 2026 /EINPresswire.com/ -- New Phase 3 clinical trial findings spanning the diagnosis, imaging, and treatment of cardiac amyloidosis will be presented at the Ame...
Here are the top stories from the past seven days.
The approach offers a contactless way to screen for common conditions earlier and more widely.
